Structural Heart Imaging Market to Attain USD 15.82 Bn by 2033


12 Nov 2024

Share : linkedin twitter facebook

The global structural heart imaging market revenue surpassed USD 9.44 billion in 2024 and is predicted to attain around USD 15.82 billion by 2033, growing at a CAGR of 5.91%. The demand for structural heart imaging market services is increasing due to the rising prevalence of cardiac diseases among the majority of the population.

Structural Heart Imaging Market Statistics

Market Overview

Structural heart imaging is a technique that is extensively utilized in the healthcare industry for screening and examining the heart at the molecular level. The procedure includes the use of light reflection to generate images of interior parts along with the 2D cross-section analysis. It is then utilized in processing and enabling professionals to perform various operative procedures, such as detecting blockages in the arteries.

Report Highlights of the Structural Heart Imaging Market 

  • By modality, the angiogram segment dominated the structural heart imaging market in 2023. The dominance of the segment can be attributed to the rising research activities, improved devices, and sophisticated techniques.
  • By modality, the computed tomography (CT) segment is anticipated to grow at the fastest rate in the market over the forecast period. The growth of the segment can be linked to the increasing demand to identify treatment efficiency.
  • By procedure, the transcatheter aortic valve replacement (TAVR) segment led the global market in 2023. The dominance of the segment can be linked to the rising utilization of TAVR in the treatment of high-risk heart disorder patients.
  • By procedure, the surgical aortic valve replacement (SAVR) segment is anticipated to grow at a significant rate in the market during the forecast period. The growth of the segment can be linked to the increase in the elderly population with aortic valve problems.
  • By end-use, the hospital segment dominated the market in 2023. This growth can be attributed to the enhanced healthcare infrastructure of hospitals and clinics.
  • By application, in 2023, the valvular heart disease segment held the largest share of the market. This is because of the increasing prevalence of diseases such as rheumatic fever and blood infections.
  • By application, the congenital heart disease segment is projected to grow at the fastest rate in the market over the study period. The growth of the segment is driven by a rise in birth rates across the globe.
  • By end-use, the ambulatory surgical centers segment is expected to show the fastest growth over the projected period. The dominance of the segment can be driven by a rise in the infrastructure and availability of equipment.

Technological advancements

New tools and techniques in the structural heart imaging market have enhanced the patient experience and decreased the requirement for invasive procedures. For instance, transcatheter aortic valve replacement is a minimally invasive procedure that also has a quick recovery time and fewer complexities. In addition, individuals prefer this procedure over standard ones because they offer shorter hospital stays and less pain.

  • In December 2022, Echo IQ launched its cloud-based platform for screening structural heart disease in the United States. It supports the detection of structural heart diseases, such as guideline-defined aortic stenosis, and automates this process using AI. 

Increase in the frequency of structural heart diseases

Heart devices include annuloplasty rings and heart valve balloon occludes. If the heart has a leaky valve or large size these devices tighten and restructure the hindrances around the heart. Due to the rising number of cardiovascular conditions the demand for the structural heart imaging market is increasing. Moreover, heart valves keep the blood flowing in the heart in the right direction.

New and innovative product launches

New drug approvals and product launches are the main factors impacting the growth of the structural heart imaging market. Also, there are substantial innovations in these devices to fulfill the demand for appropriate diagnosis and treatment. 

Regional Snapshot

North America dominated the structural heart imaging market in 2023. The dominance of the region can be linked to the increase in the prevalence of cardiovascular diseases in the region coupled with the huge spending on healthcare infrastructure. Furthermore, the US dominated the market in the North American region because of the high consumption of alcohol among a vast population which has led to escalating incidence of heart diseases in the region.

Asia Pacific is expected to grow at the fastest rate in the structural heart imaging market over the projected period. The growth of the region can be driven by the rise in the elderly population in the region and the region's increase in expenditure on research for cardiovascular conditions. Moreover, in developing countries like China and India, a large number of the population is suffering from work-related stress.

Structural Heart Imaging Market Coverage

Report Attribute Key Statistics
Market Revenue in 2024 USD 9.44 Billion
Market Revenue by 2033 USD 15.82 Billion
CAGR 5.91% from 2024 to 2033
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2023
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market News 

  • In May 2024, Teleflex Incorporate, a top global provider of medical technologies, announced that the Wattson Temporary Pacing Guidewire limited market release has commenced at Columbia University Irving Medical Center. 
  • In May 2022, Philips announced the international launch of EchoNavigator 4.0, the new release of its image-guided therapy solution for the treatment of structural heart disease. 

Market Segmentation

By Modality

  • Echocardiogram
  • Angiogram
  • CT
  • MRI
  • Nuclear Imaging
  • Others

By Procedure 

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Surgical Aortic Valve Replacement (SAVR)
  • Transcatheter Mitral Valve Repair (TMVR)
  • Left Atrial Appendage Closure (LAAC)
  • Annuloplasty
  • Valvuloplasty
  • Others

By Application

  • Valvular Heart Disease
  • Congenital Heart Disease

By End-use 

  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Others

Get this report to explore global market size, share, CAGR and trends, featuring detailed segmental analysis and an insightful competitive landscape overview@ https://www.precedenceresearch.com/checkout/5227

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344

Related Reports